Depression and its management by Saraswata Churna Takra-Dhara and Go Ghrita Nasya

A Clinical study of Saraswata Churna and Takra-Dhara along with Gavya Ghrita Nasya in the management of Manoavsad

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016722

Enrollment

Registered

2018-12-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F329- Major depressive disorder, singleepisode, unspecified

Interventions

Intervention1: Saraswata churna: two dose of 1gm Saraswata churna orally with 2.5ml gavya ghrita and 5ml madhu after meals for 60 days Control Intervention1: Saraswat Churna and Takra Dhara along with

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed as per the criteria for mild and moderate depression as per BDI(Beck Depression Inventory). 2.Age between 16 to 50 years. 3.Patients of either gender,irrespective of socioeconomic status. 4.Patients with history of depression less than two year. 5.Patients who were under medication for depression previously but not using now. 6.Patients ready to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with other psychiatric disorders. 2.Depressive phase of substance abuse disorder. 3.Pregnant women. 4.Patients with suicidal tendency/thoughts. 5.Post Schizophrenic Depression. 6.Patients with Hypotension.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameterTimepoint: 2 months	—

Secondary

Measure	Time frame
To find the comparative efficacy of the treatments in the different groupsTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Kintul Joshi

DSRRAU,Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026